|
1
|
Kinoshita M, Kodera Y, Hibi K, et al: Gene
expression profile of 5-fluorouracil metabolic enzymes in primary
colorectal cancer: potential as predictive parameters for response
to fluorouracil-based chemotherapy. Anticancer Res. 27:851–856.
2007.
|
|
2
|
Okumura K, Shiomi H, Mekata E, et al:
Correlation between chemosensitivity and mRNA expression level of
5-fluorouracil-related metabolic enzymes during liver metastasis of
colorectal cancer. Oncol Rep. 15:875–882. 2006.
|
|
3
|
Aschele C, Debernardis D, Casazza S, et
al: Immunohisto chemical quantitation of thymidylate synthase
expression in colorectal cancer metastases predicts for clinical
outcome to fluorouracil-based chemotherapy. J Clin Oncol.
17:1760–1770. 1999.
|
|
4
|
Soong R, Shah N, Salto-Tellez M, et al:
Prognostic significance of thymidylate synthase, dihydropyrimidine
dehydrogenase and thymidine phosphorylase protein expression in
colorectal cancer patients treated with or without
5-fluorouracil-based chemotherapy. Ann Oncol. 19:915–919. 2008.
|
|
5
|
Bruey JM, Ducasse C, Bonniaud P, et al:
Hsp27 negatively regulates cell death by interacting with
cytochrome c. Nat Cell Biol. 2:645–652. 2000.
|
|
6
|
Mehlen P, Schulze-Osthoff K and Arrigo AP:
Small stress proteins as novel regulators of apoptosis. Heat shock
protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. J
Biol Chem. 271:16510–16514. 1996.
|
|
7
|
Andrieu C, Taieb D, Baylot V, et al: Heat
shock protein 27 confers resistance to androgen ablation and
chemotherapy in prostate cancer cells through eIF4E. Oncogene.
29:1883–1896. 2010.
|
|
8
|
Sarto C, Valsecchi C, Magni F, et al:
Expression of heat shock protein 27 in human renal cell carcinoma.
Proteomics. 4:2252–2260. 2004.
|
|
9
|
Song TF, Zhang ZF, Liu L, Yang T, Jiang J
and Li P: Small interfering RNA-mediated silencing of heat shock
protein 27 (HSP27) Increases chemosensitivity to paclitaxel by
increasing production of reactive oxygen species in human ovarian
cancer cells (HO8910). J Int Med Res. 37:1375–1388. 2009.
|
|
10
|
Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO,
Welch WJ and McGuire WL: Response of human breast cancer cells to
heat shock and chemotherapeutic drugs. Cancer Res. 52:3648–3654.
1992.
|
|
11
|
Vargas-Roig LM, Gago FE, Tello O, Aznar JC
and Ciocca DR: Heat shock protein expression and drug resistance in
breast cancer patients treated with induction chemotherapy. Int J
Cancer. 79:468–475. 1998.
|
|
12
|
Garrido C, Mehlen P, Fromentin A, et al:
Inconstant association between 27-kDa heat-shock protein (Hsp27)
content and doxorubicin resistance in human colon cancer cells. The
doxorubicin-protecting effect of Hsp27. Eur J Biochem. 237:653–659.
1996.
|
|
13
|
Choi DH, Ha JS, Lee WH, et al: Heat shock
protein 27 is associated with irinotecan resistance in human
colorectal cancer cells. FEBS Lett. 581:1649–1656. 2007.
|
|
14
|
Tweedle EM, Khattak I, Ang CW, et al: Low
molecular weight heat shock protein HSP27 is a prognostic indicator
in rectal cancer but not colon cancer. Gut. 59:1501–1510. 2010.
|
|
15
|
Yu Z, Zhi J, Peng X, Zhong X and Xu A:
Clinical significance of HSP27 expression in colorectal cancer. Mol
Med Report. 3:953–958. 2010.
|
|
16
|
Wang F, Zhang P, Shi C, Yang Y and Qin H:
Immunohisto chemical detection of HSP27 and hnRNP K as prognostic
and predictive biomarkers for colorectal cancer. Med Oncol.
29:1780–1788. 2012.
|
|
17
|
Tsuruta M, Nishibori H, Hasegawa H, et al:
Heat shock protein 27, a novel regulator of 5-fluorouracil
resistance in colon cancer. Oncol Rep. 20:1165–1172. 2008.
|
|
18
|
Hayashi R, Ishii Y, Ochiai H, et al:
Suppression of heat shock protein 27 expression promotes
5-fluorouracil sensitivity in colon cancer cells in axenograft
model. Oncol Rep. 28:1269–1274. 2012.
|
|
19
|
Kostenko S and Moens U: Heat shock protein
27 phosphorylation: kinases, phosphatases, functions and pathology.
Cell Mol Life Sci. 66:3289–3307. 2009.
|
|
20
|
Cuenda A, Rouse J, Doza YN, et al:
SB203580 is a specific inhibitor of a MAP kinase homologue which is
stimulated by cellular stress and interleukin-1. FEBS Lett.
364:229–233. 1995.
|
|
21
|
Benjamin IJ and McMillan DR: Stress (heat
shock) proteins: molecular chaperones in cardiovascular biology and
disease. Circ Res. 83:117–132. 1998.
|
|
22
|
Lambert H, Charette SJ, Bernier AF, et al:
HSP27 multimerization mediated by phosphorylation-sensitive
intermolecular interactions at the amino terminus. J Biol Chem.
274:3978–9385. 1999.
|
|
23
|
Landry J, Lambert H, Zhou M, et al: Human
HSP27 is phosphorylated at serines 78 and 82 by heat shock and
mitogen-activated kinases that recognize the same amino acid motif
as S6 kinase II. J Biol Chem. 267:794–803. 1992.
|
|
24
|
Rouse J, Cohen P, Trigon S, et al: A novel
kinase cascade triggered by stress and heat shock that stimulates
MAPKAP kinase-2 and phosphorylation of the small heat shock
proteins. Cell. 78:1027–1037. 1994.
|
|
25
|
Geum D, Son GH and Kim K:
Phosphorylation-dependent cellular localization and
thermoprotective role of heat shock protein 25 in hippocampal
progenitor cells. J Biol Chem. 277:19913–19921. 2002.
|
|
26
|
Hotte SJ, Yu EY, Hirte HW, et al: Phase I
trial of OGX-427, a 2′methoxyethyl antisense oligonucleotide (ASO),
against heat shock protein 27 (Hsp27): Final results. J Clin Oncol.
28(15s): abstr. 3077. 2010.
|
|
27
|
Lamoureux F, Thomas C, Yin MJ, et al:
Suppression of heat shock protein 27 using OGX-427 induces
endoplasmic reticulum stress and potentiates heat shock protein 90
inhibitors to delay castrate-resistant prostate cancer. Eur Urol.
66:145–155. 2014.
|
|
28
|
Paul C, Simon S, Gilbert B, et al: Dynamic
pr Paul C, Simon S, Gilbert B, et al: Dynamic processes that
reflect anti-apoptotic strategies set up by HspB1 (Hsp27). Exp Cell
Res. 316:1535–1552. 2010.
|
